; and (v) for which the wholesale acquisition cost (as defined in section 1847A(c)(6)(B)), for a monthly supply does not exceed the monthly specialty-tier cost threshold as determined by the Secretary from time to time. ; and (2) in subsection (c), by adding at the end the following new paragraph: (7) Treatment of cost-sharing for qualifying non-opioid pain management drugs The coverage is provided in accordance with subsection (b)(10). . (b) Conforming amendments to cost-sharing for low-income individuals Section 1860D–14(a) of the Social Security Act ( 42 U.S.C. 1395w–114(a) ) is amended— (1) in paragraph (1)(D), in each of the clauses (ii) and (iii), by striking Subject to paragraph (6) and inserting Subject to paragraphs (6) and (7) ; (2) in paragraph (2)— (A) in subparagraph (B), by striking Subject to paragraphs (8) and (9) and inserting Subject to paragraphs (8), (9), and (10) ; (B) in subparagraph (D), by striking Subject to paragraph (6) and inserting Subject to paragraphs (6) and (7) ; and (C) in subparagraph (E), by striking Subject to paragraph (6) and inserting Subject to paragraphs (6) and (7) ; and (3) by adding at the end the following new paragraph: (7) No application of cost-sharing or deductible for qualifying non-opioid pain management drugs For plan years beginning on or after January 1, 2025, with respect to a covered part D drug that is a qualifying non-opioid pain management drug (as defined in section 1860D–2(b)(10)(B))— (A) the deductible under section 1860D-2(b)(1) shall not apply